1. Home
  2. MCHX vs DXR Comparison

MCHX vs DXR Comparison

Compare MCHX & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.56

Market Cap

66.3M

ML Signal

HOLD

Logo Daxor Corporation

DXR

Daxor Corporation

N/A

Current Price

$9.83

Market Cap

71.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCHX
DXR
Founded
2003
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
71.4M
IPO Year
2003
1995

Fundamental Metrics

Financial Performance
Metric
MCHX
DXR
Price
$1.56
$9.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.3K
12.2K
Earning Date
03-25-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,291,000.00
$1,446,345.00
Revenue This Year
$9.12
$44,935.22
Revenue Next Year
N/A
$74.79
P/E Ratio
N/A
$33.83
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$7.10
52 Week High
$2.30
$14.76

Technical Indicators

Market Signals
Indicator
MCHX
DXR
Relative Strength Index (RSI) 52.99 24.39
Support Level $1.35 $8.45
Resistance Level $1.76 $9.88
Average True Range (ATR) 0.09 0.43
MACD 0.02 -0.09
Stochastic Oscillator 65.84 4.69

Price Performance

Historical Comparison
MCHX
DXR

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: